Strong Pharmacological Activity of Locally Administered Next-Generation Antisense Oligonucleotides (ASOs) in Orthotopic Lung Cancer Mouse Models

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2015.12.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment

Clinical Cancer Research
Cancer ResearchOncology
2014English

Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy

PLoS ONE
Multidisciplinary
2014English

Specific Block of Androgen Receptor Activity by Antisense Oligonucleotides

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2003English

(423) Distribution and Efficacy of Centrally and Systemically Administered Antisense Oligonucleotides in the Pain System

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2016English

Downregulation of Human Polo-Like Kinase Activity by Antisense Oligonucleotides Induces Growth Inhibition in Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Mouse Models for Human Lung Cancer

Genes and Development
GeneticsDevelopmental Biology
2005English

Best Minimally Modified Antisense Oligonucleotides According to Cell Nuclease Activity

Antisense and Nucleic Acid Drug Development
2001English

Antisense Oligonucleotides Extend Survival and Reverse Decrement in Muscle Response in ALS Models

Journal of Clinical Investigation
Medicine
2018English

Characterization of Stereoisomerism of Antisense Oligonucleotides.

NIPPON KAGAKU KAISHI
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy